338 related articles for article (PubMed ID: 35001170)
41. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
[TBL] [Abstract][Full Text] [Related]
42. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H
Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355
[TBL] [Abstract][Full Text] [Related]
43. CACUL1/CAC1 attenuates p53 activity through PML post-translational modification.
Fukuda T; Kigoshi-Tansho Y; Naganuma T; Kazaana A; Okajima T; Tsuruta F; Chiba T
Biochem Biophys Res Commun; 2017 Jan; 482(4):863-869. PubMed ID: 27889610
[TBL] [Abstract][Full Text] [Related]
44. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway.
Lallemand-Breitenbach V; Jeanne M; Benhenda S; Nasr R; Lei M; Peres L; Zhou J; Zhu J; Raught B; de Thé H
Nat Cell Biol; 2008 May; 10(5):547-55. PubMed ID: 18408733
[TBL] [Abstract][Full Text] [Related]
45. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
Liu Y; Zhao D; Qiu F; Zhang LL; Liu SK; Li YY; Liu MT; Wu D; Wang JX; Ding XQ; Liu YX; Dong CJ; Shao XQ; Yang BF; Chu WF
Mol Ther; 2017 Mar; 25(3):666-678. PubMed ID: 28143738
[TBL] [Abstract][Full Text] [Related]
46. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
[TBL] [Abstract][Full Text] [Related]
47. Sumoylation of the Tumor Suppressor Promyelocytic Leukemia Protein Regulates Arsenic Trioxide-Induced Collagen Synthesis in Osteoblasts.
Xu WX; Liu SZ; Wu D; Qiao GF; Yan J
Cell Physiol Biochem; 2015; 37(4):1581-91. PubMed ID: 26517826
[TBL] [Abstract][Full Text] [Related]
48. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation.
Gao C; Ho CC; Reineke E; Lam M; Cheng X; Stanya KJ; Liu Y; Chakraborty S; Shih HM; Kao HY
Mol Cell Biol; 2008 Sep; 28(18):5658-67. PubMed ID: 18625722
[TBL] [Abstract][Full Text] [Related]
49. Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection.
Ribet D; Lallemand-Breitenbach V; Ferhi O; Nahori MA; Varet H; de Thé H; Cossart P
mBio; 2017 Jan; 8(1):. PubMed ID: 28074026
[TBL] [Abstract][Full Text] [Related]
50. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
[TBL] [Abstract][Full Text] [Related]
51. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
[TBL] [Abstract][Full Text] [Related]
52. SUMOylation by SUMO2 is implicated in the degradation of misfolded ataxin-7 via RNF4 in SCA7 models.
Marinello M; Werner A; Giannone M; Tahiri K; Alves S; Tesson C; den Dunnen W; Seeler JS; Brice A; Sittler A
Dis Model Mech; 2019 Jan; 12(1):. PubMed ID: 30559154
[TBL] [Abstract][Full Text] [Related]
53. In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.
Saitoh N; Uchimura Y; Tachibana T; Sugahara S; Saitoh H; Nakao M
Exp Cell Res; 2006 May; 312(8):1418-30. PubMed ID: 16688858
[TBL] [Abstract][Full Text] [Related]
54. The important roles of protein SUMOylation in the occurrence and development of leukemia and clinical implications.
Zhao B; Zhang Z; Chen X; Shen Y; Qin Y; Yang X; Xing Z; Zhang S; Long X; Zhang Y; An S; Wu H; Qi Y
J Cell Physiol; 2021 May; 236(5):3466-3480. PubMed ID: 33151565
[TBL] [Abstract][Full Text] [Related]
55. Puromycin induces SUMO and ubiquitin redistribution upon proteasome inhibition.
Matsumoto H; Saitoh H
Biochem Biophys Res Commun; 2016 Jul; 476(3):153-8. PubMed ID: 27181354
[TBL] [Abstract][Full Text] [Related]
56. Promyelocytic leukemia protein promotes the phenotypic switch of smooth muscle cells in atherosclerotic plaques of human coronary arteries.
Karle W; Becker S; Stenzel P; Knosalla C; Siegel G; Baum O; Zakrzewicz A; Berkholz J
Clin Sci (Lond); 2021 Apr; 135(7):887-905. PubMed ID: 33764440
[TBL] [Abstract][Full Text] [Related]
57. Identification of proximal SUMO-dependent interactors using SUMO-ID.
Barroso-Gomila O; Trulsson F; Muratore V; Canosa I; Merino-Cacho L; Cortazar AR; Pérez C; Azkargorta M; Iloro I; Carracedo A; Aransay AM; Elortza F; Mayor U; Vertegaal ACO; Barrio R; Sutherland JD
Nat Commun; 2021 Nov; 12(1):6671. PubMed ID: 34795231
[TBL] [Abstract][Full Text] [Related]
58. Trafficking of the transcription factor Nrf2 to promyelocytic leukemia-nuclear bodies: implications for degradation of NRF2 in the nucleus.
Malloy MT; McIntosh DJ; Walters TS; Flores A; Goodwin JS; Arinze IJ
J Biol Chem; 2013 May; 288(20):14569-14583. PubMed ID: 23543742
[TBL] [Abstract][Full Text] [Related]
59. The Viral SUMO-Targeted Ubiquitin Ligase ICP0 is Phosphorylated and Activated by Host Kinase Chk2.
Hembram DSS; Negi H; Biswas P; Tripathi V; Bhushan L; Shet D; Kumar V; Das R
J Mol Biol; 2020 Mar; 432(7):1952-1977. PubMed ID: 32001251
[TBL] [Abstract][Full Text] [Related]
60. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
